ResMed holds the cleaner structural position, with valuation as the main driver and profitability adding further support. Coloplast A/S does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (COLO-B.CO: STOXX 600, RMD: S&P 500).
Most of the visible separation comes from valuation. The overall score gap is 22 points in favour of ResMed Inc..
Both operate in: Medical Instruments & Supplies
This comparison is based on industry proximity, not on functional trajectory similarity. COLO-B.CO and RMD share the same industry classification.
For a similarity-based comparison, see how Coloplast A/S and ResMed each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
ResMed Inc. looks stronger on relative valuation, while the broader price setup remains mixed.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where COLO-B.CO and RMD each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The multiple-based pricing edge comes from a trailing P/E that is 23.3 turns lower.
Coloplast A/S still looks less cycle-sensitive — that keeps the result from looking completely one-sided.
Valuation is the clearest driver, and profitability also supports ResMed Inc.'s broader structural position.
Break down the COLO-B.CO vs RMD comparison across all dimensions with the full interactive tool.
Explore how COLO-B.CO and RMD each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.